Bullous Pemphigoid

Incidence and onset information

Researches and researchers

Doctors, researchs, and experts related to Bullous Pemphigoid extracted from public data.

Bullous Pemphigoid Experts map

Current Researchs and researchers

• ROUEN — Pr Pascal JOLY

  Coordinator of expert centre - Clinical expert - Principal investigator of clinical trial - Investigator of research project
  
  

  • Institution/s:
    — CHU de Rouen
    — Clinique dermatologique, CHU de Rouen
    — INSERM U 905 IFRMP 23, Faculté de médecine et de pharmacie de Rouen
  • Research area/topic::
    

    Study of B clone specific of Desmogleines and antigens of bullous pemphigoid



• GÖTTINGEN — Pr Ibrahim ADHAM

  Responsible for diagnostic tests - Investigator of research project
  
  

  • Institution/s:
    — Institut für Humangenetik der Universität Göttingen
  • Research area/topic::
    

    KFO 303: Pemphigoid Diseases - Molecular Pathways and their Therapeutic Potential : Genetics of Pemphigoid Diseases in human - DE



• LÜBECK — Pr Detlef ZILLIKENS

  Coordinator of expert centre - Clinical expert - Principal investigator of clinical trial - Coordinator of research network - Director of department
  
  

  • Institution/s:
    — Universitätsklinikum Schleswig-Holstein - Campus Lübeck
    — Universitätsklinikum Schleswig-Holstein - Campus Lübeck
    — Klinik für Dermatologie, Allergologie und Venerologie, Universitätsklinikum Schleswig-Holstein - Campus Lübeck
  • Research area/topic::
    

    KFO 303: Pemphigoid Diseases - Molecular Pathways and their Therapeutic Potential



• LÜBECK — Pr Enno SCHMIDT

  Clinical expert - Responsible for diagnostic tests - Investigator of research project - Director of laboratory
  
  

  • Institution/s:
    — Universitätsklinikum Schleswig-Holstein - Campus Lübeck
    — Klinik für Dermatologie, Allergologie und Venerologie, Universitätsklinikum Schleswig-Holstein - Campus Lübeck
    — Universitätsklinikum Schleswig-Holstein - Campus Lübeck
  • Research area/topic::
    

    KFO 303: Pemphigoid Diseases - Molecular Pathways and their Therapeutic Potential : The skin microbiome modulating Pemphigoid Diseases - DE



• LÜBECK — Pr Ralf J. LUDWIG

  Investigator of research project - Coordinator of research network
  
  

  • Institution/s:
    — Universitätsklinikum Schleswig-Holstein - Campus Lübeck
    — Universitätsklinikum Schleswig-Holstein - Campus Lübeck
  • Research area/topic::
    

    DPem : Dimethylfumarate for the treatment of bullous pemphigoid -DE-



• MARBURG — Pr Michael HERTL

  Coordinator of expert centre - Clinical expert - Investigator of research project - Coordinator of research network
  
  

  • Institution/s:
    — Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg
  • Research area/topic::
    

    Development of pathogenetic autoimmune reactions in bullous pemphigoid

Bullous Pemphigoid Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Narcolepsy (HLA-DQB1 06:02) Genotyping. By ARUP Laboratories, Molecular Genetics and Genomics (United States). HLA-DQB1 Specificity 100 % Genes 50 %
Celiac Disease (HLA-DQ2 and HLA-DQ8) Genotyping. By ARUP Laboratories, Molecular Genetics and Genomics (United States). HLA-DQA1, HLA-DQB1 Specificity 50 % Genes 50 %
Celiac disease (HLA-DQ/DR). By CGC Genetics (Portugal). HLA-DQA1, HLA-DQB1 Specificity 50 % Genes 50 %
Lactose intolerance (MCM6 gene) and Celiac disease (HLA-DQ2/ HLA-DQ8). By CGC Genetics (Portugal). HLA-DQA1, HLA-DQB1, MCM6 Specificity 34 % Genes 50 %
Celiac Disease via Next Generation Sequencing HLA Typing. By PreventionGenetics PreventionGenetics (United States). HLA-DQA1, HLA-DQB1 Specificity 50 % Genes 50 %
Narcolepsy Risk Factor. By Bioscientia GmbH Center for Human Genetics (Germany). HLA-DQB1, HLA-DRB1 Specificity 100 % Genes 100 %
HLA DQ2/DQ8. By Furst Medical Laboratories, FurstNAT (Norway). HLA-DQA1, HLA-DQB1 Specificity 50 % Genes 50 %
Celiac Disease (HLA-DQA1*05, HLA-DQB1*02, and HLA-DQB1*03:02) Genotyping. By Molecular Genetics Laboratory Centro de Investigaciones Endocrinologicas "Dr. Cesar Bergada" (Argentina). HLA-DQA1, HLA-DQB1 Specificity 50 % Genes 50 %

Sources and references

You can check the following sources for additional information.

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like TREHALASE DEFICIENCY TOOTH AGENESIS, SELECTIVE, 1; STHAG1 HEMOCHROMATOSIS, TYPE 1; HFE1 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If; CDG1F ARTHROGRYPOSIS, DISTAL, TYPE 7; DA7